苏珊
毕业年份:2019级博士 | Email:sstuo14@126.com
2009年-2014年 复旦大学 基础医学专业 本科
2014年-2019年 复旦大学 病原生物学专业 博士
学位论文题目《新型长效HIV-1多肽类融合抑制剂的设计、活性评价及其机制研究》
发表论文:
1. Su S., Rasquinha G., et al. A peptide-based HIV-1 fusion inhibitor with two tail-anchors and palmitic acid exhibits substantially improved in vitro and ex vivo anti-HIV-1 activity and prolonged in vivo half-life. Molecules 2019 Mar 21;24(6).
2. Xu W.#, Pu J.#, Su S.#, et al. Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41. AIDS 2019
3. Su S., Ma Z., et al. Adding an Artificial Tail-Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile. Molecules 2017 Nov 20;22(11).
4. Su S.#, Wang Q.#, et al. A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity. AIDS 2017 Apr 24;31(7):885-894.
5. Su S., Zhu Y., et al. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. Journal of virology 2016 Dec 16;91(1).
6. Tan, Y.#, Wang, J.#, Su, S.#, et al. Enhancement of endocytic uptake of HIV-1 virions into CD4-negative epithelial cells by HIV-1 gp41 via its interaction with POB1. Cellular & Molecular Immunology 2017 Jun;14(6):568-571.
7. Zhu, Y #, Su, S.#, et al. Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations. Scientific reports 2016 Sep 26;6:31983.
2019 复旦大学优秀毕业生
2019 上海市医学会医学病毒分会年会优秀论文二等奖
2015, 2017, 2018 国家奖学金
2016 第一三共制药优秀学生奖学金
进一步深造
版权所有:2017年 复旦大学姜世勃课题组 沪交ICP备16018209-1 |